Sector revisions Genmab A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 11/07/2025 pm IST			5-day change	1st Jan Change
1,378.00 ^DKK	-1.18%		+6.12%	-7.67%

05:20pm	Baptista Research Begins Genmab Coverage at Outperform	MT
01/07	Genmab Announces Changes to Its Executive Committee	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	GENMAB A/S							16
	ARGENX SE							16
	BIONTECH SE							21
	WUXI APPTEC CO., LTD.							18
	SUMMIT THERAPEUTICS INC.							9
	INSMED INCORPORATED							18
	WUXI BIOLOGICS (CAYMAN) INC.							26
	AKESO, INC.							20
	EXELIXIS, INC.							19
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							16
	VERONA PHARMA PLC							9
	LEGEND BIOTECH CORPORATION							20
	MADRIGAL PHARMACEUTICALS, INC.							14
	PHARMAESSENTIA CORPORATION							4
	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.							2
	NUVALENT, INC.							10
	BIOCON LIMITED							20
	REMEGEN CO., LTD.							15
	VAXCYTE, INC.							8
	Average							15
	Weighted average by Cap.							16